Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Change in Accured Expenses: 2022-2023

Historic Change in Accured Expenses for Lexeo Therapeutics (LXEO) over the last 1 years, with Dec 2023 value amounting to -$2.1 million.

  • Lexeo Therapeutics' Change in Accured Expenses fell 133.48% to -$2.1 million in Q4 2023 from the same period last year, while for Dec 2023 it was $2.1 million, marking a year-over-year change of. This contributed to the annual value of $3.4 million for FY2024, which is 61.02% up from last year.
  • Latest data reveals that Lexeo Therapeutics reported Change in Accured Expenses of -$2.1 million as of Q4 2023, which was down 144.19% from $4.8 million recorded in Q3 2023.
  • In the past 5 years, Lexeo Therapeutics' Change in Accured Expenses registered a high of $4.8 million during Q3 2023, and its lowest value of -$2.1 million during Q4 2023.
  • Moreover, its 2-year median value for Change in Accured Expenses was -$908,000 (2022), whereas its average is $236,600.
  • Data for Lexeo Therapeutics' Change in Accured Expenses shows a maximum YoY crashed of 133.48% (in 2023) over the last 5 years.
  • Quarterly analysis of 2 years shows Lexeo Therapeutics' Change in Accured Expenses stood at -$908,000 in 2022, then slumped by 133.48% to -$2.1 million in 2023.
  • Its last three reported values are -$2.1 million in Q4 2023, $4.8 million for Q3 2023, and $1.2 million during Q2 2023.